Clinical Trial

SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition. The main question it aims to answer is whether participants assigned to SuperCAP experience a greater reduction in disability, defined as an improvement of at least 5 points on the WHODAS 2.0 from baseline to the post-intervention visit, compared with participants in the control group. Participants assigned to the SuperCAP intervention will undergo a series of sessions that include psychoeducation, adaptive cognitive training exercises, fatigue self-management strategies, and multidisciplinary content.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-07.
Trial Details
NCT Number NCT07530757
Lead Sponsor Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Collaborators: Fundació Institut Germans Trias i Pujol
Conditions Post COVID Condition
Enrollment 100 participants
Start Date 2026-07
Primary Completion 2026-11 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-07